Back
Pliant Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
9
PLRX
Pliant Therapeutics
Last Price:
12.49
Seasonality Move:
40.29%
Sell
7
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-10.02%
Sell
9
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $12.60. The Score for PLRX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- PLRX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
7
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.07. The Score for NBY is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $12.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.07
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 32.87 | Sell |
| Chaikin Money Flow: | 16614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.35 - 15.01) | Sell |
| Bollinger Bands (100): | (14.34 - 17.56) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 23.94 | Sell |
| Chaikin Money Flow: | -1130407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.09 - 0.13) | Sell |
| Bollinger Bands (100): | (0.11 - 0.23) | Sell |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.2 | Sell |
| 20-day SMA: | 14.02 | Sell |
| 50-day SMA: | 15.11 | Sell |
| 200-day SMA: | 16.12 | Sell |
| 8-day EMA: | 13.08 | Sell |
| 20-day EMA: | 13.85 | Sell |
| 50-day EMA: | 14.82 | Sell |
| 200-day EMA: | 16.7 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Sell |
| 20-day SMA: | 0.1 | Sell |
| 50-day SMA: | 0.13 | Sell |
| 200-day SMA: | 0.34 | Sell |
| 8-day EMA: | 0.08 | Sell |
| 20-day EMA: | 0.1 | Sell |
| 50-day EMA: | 0.13 | Sell |
| 200-day EMA: | 0.59 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Pliant Therapeutics Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||